Traders sold shares of Humana Inc. (NYSE:HUM) on strength during trading on Thursday. $502.66 million flowed into the stock on the tick-up and $526.62 million flowed out of the stock on the tick-down, for a money net flow of $23.96 million out of the stock. Of all companies tracked, Humana had the 0th highest net out-flow for the day. Humana traded up $13.12 for the day and closed at $171.53

HUM has been the topic of several research analyst reports. Cowen and Company reaffirmed an “outperform” rating on shares of Humana in a research report on Tuesday, April 5th. Leerink Swann reaffirmed an “outperform” rating on shares of Humana in a research report on Tuesday, April 5th. Zacks Investment Research downgraded Humana from a “hold” rating to a “sell” rating in a research report on Tuesday, April 12th. Stifel Nicolaus upped their price objective on Humana from $209.00 to $220.00 and gave the company a “buy” rating in a research report on Thursday, May 5th. Finally, Royal Bank Of Canada upped their price objective on Humana from $209.00 to $220.00 and gave the company a “sector perform” rating in a research report on Thursday, May 5th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $203.75.

The firm has a market capitalization of $26.24 billion and a P/E ratio of 24.54. The company’s 50 day moving average price is $176.56 and its 200-day moving average price is $174.33.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.81 by $0.05. The business had revenue of $13.80 billion for the quarter, compared to analysts’ expectations of $13.80 billion. The company’s revenue for the quarter was down .2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.58 EPS. On average, equities analysts predict that Humana Inc. will post $8.93 EPS for the current year.

Other hedge funds recently made changes to their positions in the company. Poplar Forest Capital LLC increased its stake in shares of Humana by 1.1% in the fourth quarter. Poplar Forest Capital LLC now owns 9,100 shares of the insurance provider’s stock valued at $1,624,000 after buying an additional 100 shares in the last quarter. Tredje AP fonden increased its position in Humana by 1.7% in the fourth quarter. Tredje AP fonden now owns 9,477 shares of the insurance provider’s stock worth $1,694,000 after buying an additional 158 shares during the period. Gamco Investors INC. ET AL increased its position in Humana by 12.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 9,620 shares of the insurance provider’s stock worth $1,717,000 after buying an additional 1,040 shares during the period. Deere & Co. increased its position in Humana by 791.1% in the fourth quarter. Deere & Co. now owns 10,078 shares of the insurance provider’s stock worth $1,799,000 after buying an additional 8,947 shares during the period. Finally, Suntrust Banks Inc. increased its position in Humana by 600.1% in the fourth quarter. Suntrust Banks Inc. now owns 10,264 shares of the insurance provider’s stock worth $1,831,000 after buying an additional 8,798 shares during the period.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.